On August 24, 2022, entrusted by Zeng Bin, Secretary-General of Chengdu High-tech Medical Association, Bu Wei, Deputy Director of the Collaborative Innovation Center for Medical-Industrial Integration of Chengdu High-tech Medical Association, led Guo Zhuoran, Senior Vice President, Vice President Xiao Xiangnan, and Senior Manager of CITIC Securities Co., Ltd. Liu Jiacheng and his party of five visited Chengdu Biotec Biotechnology Co., Ltd., Chengdu Huaxi Haiqi Pharmaceutical Technology Co., Ltd., Nuofeng Pharmaceutical (Chengdu) Co., Ltd. and Chengdu Ruiqi Medical Technology Co., Ltd. The implementation of innovative projects, product pipeline development and corporate financial services were exchanged and discussed with 4 companies.
Chengdu High-tech Medical Association and investors learned about the development status and needs of their companies through on-the-spot inspections and discussions with the four companies. Everyone believes that the platform value of the Medical Association is being fully reflected, and their efforts have won industrial capital, industrial Recognition and respect from upstream and downstream. Through inspections and discussions, we will establish innovative cooperation models, strengthen wider and deeper exchanges and cooperation, and form a cooperation model featuring information resource sharing and complementary advantages, which has laid a solid foundation for a multi-party, mutually beneficial and win-win relationship. The Medical Association will play its due role in promoting inclusive development and accelerating the transformation of scientific and technological achievements in the biomedical industry.
